Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305

P. N. Aguiar; L. A. Perry; J. Penny-Dimri; H. Babiker; H. Tadokoro; R. A. de Mello; G. L. Lopes

doi:10.1093/annonc/mdx478

Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305

P. N. Aguiar, L. A. Perry, J. Penny-Dimri, H. Babiker, H. Tadokoro, R. A. de Mello, G. L. Lopes

Surgery Monash Health

Research output: Contribution to journal › Comment / Debate › Other › peer-review

6 Citations (Scopus)

Abstract

This article has been corrected to add affiliation information and to amend the caption for Figure 6A and B.

Original language	English
Pages (from-to)	1078
Number of pages	1
Journal	Annals of Oncology
Volume	29
Issue number	4
DOIs	https://doi.org/10.1093/annonc/mdx478
Publication status	Published - 1 Apr 2018

Access to Document

10.1093/annonc/mdx478

Cite this

Aguiar, P. N., Perry, L. A., Penny-Dimri, J., Babiker, H., Tadokoro, H., de Mello, R. A., & Lopes, G. L. (2018). Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305. Annals of Oncology, 29(4), 1078. https://doi.org/10.1093/annonc/mdx478

@article{fd9a80451d974385b56940a9310e4ded,

title = "Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305",

abstract = "This article has been corrected to add affiliation information and to amend the caption for Figure 6A and B.",

author = "Aguiar, \{P. N.\} and Perry, \{L. A.\} and J. Penny-Dimri and H. Babiker and H. Tadokoro and \{de Mello\}, \{R. A.\} and Lopes, \{G. L.\}",

year = "2018",

month = apr,

day = "1",

doi = "10.1093/annonc/mdx478",

language = "English",

volume = "29",

pages = "1078",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "4",

}

Aguiar, PN, Perry, LA, Penny-Dimri, J, Babiker, H, Tadokoro, H, de Mello, RA & Lopes, GL 2018, 'Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305', Annals of Oncology, vol. 29, no. 4, pp. 1078. https://doi.org/10.1093/annonc/mdx478

Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305. / Aguiar, P. N.; Perry, L. A.; Penny-Dimri, J. et al.
In: Annals of Oncology, Vol. 29, No. 4, 01.04.2018, p. 1078.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Erratum

T2 - The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305

AU - Aguiar, P. N.

AU - Perry, L. A.

AU - Penny-Dimri, J.

AU - Babiker, H.

AU - Tadokoro, H.

AU - de Mello, R. A.

AU - Lopes, G. L.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - This article has been corrected to add affiliation information and to amend the caption for Figure 6A and B.

AB - This article has been corrected to add affiliation information and to amend the caption for Figure 6A and B.

UR - https://www.scopus.com/pages/publications/85046624282

U2 - 10.1093/annonc/mdx478

DO - 10.1093/annonc/mdx478

M3 - Comment / Debate

C2 - 29267838

AN - SCOPUS:85046624282

SN - 0923-7534

VL - 29

SP - 1078

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -

Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305

Abstract

Access to Document

Other files and links

Research output

The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC

Cite this